Description
549-A00186 - 549-10-3-069-0544 - NITROSTAT 0.4 MG - NOVIS PHARMACEUTICAL LLC - PHARMACY SERVICE - FY 10
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2010-05-17+$24,990= $24,990
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2010-05-17 | +$24,990 | $24,990 | 549-A00186 - 549-10-3-069-0544 - NITROSTAT 0.4 MG - NOVIS PHARMACEUTICAL LLC - PHARMACY SERVICE - FY 10 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SJ7VH2LMC4J3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA26317P0008 | 437-FARGO VA MEDICAL CENTER (00437) · 6505 · DRUGS AND BIOLOGICALS | $4,975 | FY2017 |
| VA25715P2626 | 257-NETWORK CONTRACT OFFICE 17 · 6810 · CHEMICALS | $10,953 | FY2015 |
| VA25715C0144 | 257-NETWORK CONTRACT OFFICE 17 · 6810 · CHEMICALS | $12,870 | FY2015 |
| VA25715C0119 | 257-NETWORK CONTRACT OFFICE 17 · 6505 · DRUGS AND BIOLOGICALS | $32,113 | FY2015 |
| VA25715P0387 | 549-DALLAS · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $19,880 | FY2015 |
| VA25714C0122 | 257-NETWORK CONTRACT OFFICE 17 · 6505 · DRUGS AND BIOLOGICALS | $102,600 | FY2014 |
Other recipients under 6505 from 549-DALLAS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25716P0113 | MCKESSON CORPORATION | 549-DALLAS | $11,630 | FY2016 |
| VA25716P0178 | MICROGENICS CORPORATION | 549-DALLAS | $109,260 | FY2016 |
| VA25715J2597 | GRIFOLS BIOLOGICALS LLC | 549-DALLAS | $129,005 | FY2015 |
| VA25715C0028 | BARD PERIPHERAL VASCULAR, INC. | 549-DALLAS | $11,400 | FY2015 |
| VA25714J3693 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 549-DALLAS | $7,512 | FY2014 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA549A00186_3600_-NONE-_-NONE- · retrieved 2026-09-26.